World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
13656
World Ranking
2262
National Ranking
1093

Overview

Alan S. Cross is affiliated with the University of Maryland, Baltimore, in the United States. Their research predominantly spans the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine. Within these areas, they have contributed to specialized subfields including Epidemiology, Molecular Medicine, Molecular Biology, Immunology, and Endocrinology.

Their published work addresses multiple topics with a notable focus on Antibiotic Resistance in Bacteria and Pneumonia and Respiratory Infections. Additional topics of study include Bacterial biofilms and quorum sensing, Immune Response and Inflammation, Infant Nutrition and Health, Burn Injury Management and Outcomes, and Escherichia coli research studies.

Among their frequently published venues are Vaccines, Scientific Reports, Infection and Immunity, mBio, and The Journal of Infectious Diseases. These platforms have hosted numerous contributions by Alan S. Cross across their research areas.

Recent papers by Alan S. Cross demonstrate work in infectious disease microbiology and vaccine research, including:

  • The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection, 2020, Frontiers in Microbiology
  • Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection, 2022, BMC Microbiology
  • Vaccine value profile for Klebsiella pneumoniae, 2024, Vaccine
  • Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines, 2021, Vaccines
  • MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection, 2021, Scientific Reports

Collaboration is a significant aspect of their research approach, with frequent co-authors including Sharon M. Tennant, Myeongjin Choi, Raphael Simon, Scott M. Baliban, and Surekha Shridhar. These partnerships have contributed to the development and dissemination of work across related scientific questions and challenges.

Best Publications

  • Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

    M. Berger;J. O'Shea;A. S. Cross;T. M. Folks

  • Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

    Aaron P Rapoport;Edward A Stadtmauer;Nicole Aqui;Ashraf Badros

  • The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

    Kwang Sik Kim;Hideo Itabashi;Peter Gemski;Jerald Sadoff

  • Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

    A S Cross;J C Sadoff;N Kelly;E Bernton

  • Choice of bacteria in animal models of sepsis

    A S Cross;S M Opal;J C Sadoff;P Gemski

  • Efficacy of a Monoclonal Antibody Directed against Tumor Necrosis Factor in Protecting Neutropenic Rats from Lethal Infection with Pseudomonas aeruginosa

    Steven M. Opal;Alan S. Cross;Niamh M. Kelly;Jerald C. Sadoff

  • Febrile core temperature is essential for optimal host defense in bacterial peritonitis.

    Qinqqi Jiang;Alan S. Cross;Ishwar S. Singh;T. Timothy Chen

  • Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

    Michael Boeckh;Michael Boeckh;Janet Englund;Janet Englund;Yufeng Li;Carole Miller

  • Gamma Interferon Augments Macrophage Activation by Lipopolysaccharide by Two Distinct Mechanisms, at the Signal Transduction Level and via an Autocrine Mechanism Involving Tumor Necrosis Factor Alpha and Interleukin-1

    Thomas K. Held;Xiao Weihua;Liang Yuan;Dhananjaya V. Kalvakolanu

  • Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends

    Alan Cross;James R. Allen;John Burke;Georges Ducel

  • CLINICAL TRIALS FOR SEVERE SEPSIS: Past Failures, and Future Hopes

    Steven M. Opal;Alan S. Cross

  • Inflammatory Cytokines Produced in Response to Experimental Human Gonorrhea

    Kyle H. Ramsey;Herman Schneider;Alan S. Cross;John W. Boslego

  • The Importance of the K1 Capsule in Invasive Infections Caused by Escherichia coli

    Alan S. Cross;Peter Gemski;Jerald C. Sadoff;Frits Ørskov

  • TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia

    Ping Gong;Daniel J. Angelini;Shiqi Yang;Guanjun Xia

  • Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

    Aaron P. Rapoport;Nicole A. Aqui;Edward A. Stadtmauer;Dan T. Vogl

  • Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP.

    D L Hoover;A M Friedlander;L C Rogers;I K Yoon

  • The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.

    A. Cross;L. Asher;M. Seguin;Liang Yuan

  • Gene expression profiles differentiate between sterile SIRS and early sepsis.

    Steven B. Johnson;Matthew Lissauer;Grant V. Bochicchio;Richard Moore

  • Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

    Aaron P. Rapoport;Nicole A. Aqui;Edward A. Stadtmauer;Dan T. Vogl

  • Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice.

    Wenju Lu;Akinori Hisatsune;Takeshi Koga;Takeshi Koga;Kosuke Kato;Kosuke Kato

  • Murine Macrophages Kill the Vegetative Form of Bacillus anthracis

    Tae Jin Kang;Matthew J. Fenton;Matthew A. Weiner;Stephen Hibbs

Frequent Co-Authors

Steven M. Opal
Steven M. Opal Brown University
Jerald C. Sadoff
Jerald C. Sadoff Janssen (Belgium)
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
Jeffrey D. Hasday
Jeffrey D. Hasday University of Maryland, Baltimore
Wendell D. Zollinger
Wendell D. Zollinger Walter Reed Army Institute of Research
Dhananjaya V. Kalvakolanu
Dhananjaya V. Kalvakolanu University of Maryland, Baltimore
Stefanie N. Vogel
Stefanie N. Vogel University of Maryland, Baltimore
Gerald M. Rosen
Gerald M. Rosen University of Maryland, Baltimore
Erik P. Lillehoj
Erik P. Lillehoj University of Maryland, Baltimore
Lai-Xi Wang
Lai-Xi Wang University of Maryland, College Park

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their expertise in immunology, exploring related online degrees can open numerous career pathways in healthcare and research. Programs like an nurse practitioner accelerated program offer a fast-track route for professionals aiming to become nurse practitioners, combining rigorous training with flexible online study options.

Registered nurses without a prior nursing background can also kickstart their careers through online RN programs for non nurses in Florida, which provide foundational knowledge essential for patient care and immunology-related clinical roles.

For those already holding family nurse practitioner credentials, transitioning to specialized fields via an FNP to acute care NP bridge program can enhance skills applicable to more acute and critical care settings, often intersecting with immunology in managing complex conditions.

Understanding financial prospects is also crucial when choosing your educational path. Insights on earnings, such as how much does a DNP make, reveal that advanced degrees in nursing and health sciences typically lead to improved salary potential, making investment in education worthwhile.

Best Scientists Citing Alan S. Cross

Trending Scientists